黃芪가 자궁내막증 유발 흰쥐에 미치는 영향
Effects of Astragalus membranaceus on Surgically Induced Endometriosis in Rats
2
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
Purpose: Astragalus membranaceus is a herb which has effectiveness of energy increase, protection against pathogenic and organ immune response control. Endometriosis has been thought to be related with immune response in uterus. Therefore in this study, the effects of Astragalus membranaceus on endometriosis were investigated. Methods: The endometrial tissue was autografted to rat's small intestine. Rats with surgically induced endometriosis was administerd with Astragalus membranaceus extracts for 40 days orally or rectally. We observed the size of ectopic uterine implants at the mesenteric with the naked eye and examined the concentrations of estradiol, progesterone, TNF-α and IL-2, IL-4, IL-6 and IL-10 in serum. Also, we inquired out the efficiency between oral and rectal administration groups. Results: The size of ectopic uterine implants of oral and rectal treated groups were much smaller than those of control groups. The concentration of estradiol, progesterone, TNF-α and IL-2 were significantly decreased in oral administration experimental group compared with the control group. The concentration of progesterone were significantly decreased in rectal administration experimental group compared with the control group. The efficiency of oral administration group was better than that of rectal administration group in the serum concentration of estradiol, TNF-α and IL-2. Conclusion: Our data suggest that Astragalus membranaceus reduce the size of ectopic uterine implants at the mesenteric wall and inhibit the growth of ectopic uterine implants. Judging from the above results, it can be suggested that Astragalus membranaceus should be a useful agent for inhibiting the proliferation of uterine endometrial tissue. May be, oral administration of Astragalus membranaceus is more effective than rectal administration for inhibiting the proliferation of endometriosis.
Abstract
Purpose: Astragalus membranaceus is a herb which has effectiveness of energy increase, protection against pathogenic and organ immune response control. Endometriosis has been thought to be related with immune response in uterus. Therefore in this study, the effects of Astragalus membranaceus on endometriosis were investigated. Methods: The endometrial tissue was autografted to rat's small intestine. Rats with surgically induced endometriosis was administerd with Astragalus membranaceus extracts for 40 days orally or rectally. We observed the size of ectopic uterine implants at the mesenteric with the naked eye and examined the concentrations of estradiol, progesterone, TNF-α and IL-2, IL-4, IL-6 and IL-10 in serum. Also, we inquired out the efficiency between oral and rectal administration groups. Results: The size of ectopic uterine implants of oral and rectal treated groups were much smaller than those of control groups. The concentration of estradiol, progesterone, TNF-α and IL-2 were significantly decreased in oral administration experimental group compared with the control group. The concentration of progesterone were significantly decreased in rectal administration experimental group compared with the control group. The efficiency of oral administration group was better than that of rectal administration group in the serum concentration of estradiol, TNF-α and IL-2. Conclusion: Our data suggest that Astragalus membranaceus reduce the size of ectopic uterine implants at the mesenteric wall and inhibit the growth of ectopic uterine implants. Judging from the above results, it can be suggested that Astragalus membranaceus should be a useful agent for inhibiting the proliferation of uterine endometrial tissue. May be, oral administration of Astragalus membranaceus is more effective than rectal administration for inhibiting the proliferation of endometriosis.
참고문헌 (69)
- "Endometriosis and infertility", 81(5), pp.1441~1446 (2004)
- "New advances in the understanding of endometriosis related infertility", 55, pp.73~83 (2002)
- "여성생식의학", pp.413~427 (1998), 서울:대관출판사
- "그림으로 보는 여성의학", pp.246~ (2005), 서울:정담
- "The immune system in endometriosis The current status of endometriosis", pp.223~30 (1993), the Porthenon Publishing group
- "Deficient cellular immunity in endometriosis", pp.377~383 (1981)
- "Status of current research on endometriosis", 43, pp.252~262 (1998)
- "Immunomodulation in women with endometriosis receiving GnRH agonist", 89(6), pp.993~998 (1997)
- "Immunobiology of endometriosis", 75(1), pp.1~10 (2001)
- "Endometriosis", 364, pp.1789~1799 (2004)
- "한의부인과학 상권", pp.186~188 (2001), 서울:정담출판사
- "血府逐瘀湯이 子宮內膜症 白鼠에 미치는 影響", 18(2), pp.273~282 (1997)
- "桃紅四物湯이 子宮內膜症을 유발한 흰쥐에 미치는 영향", 19(1), pp.125~138 (2006)
- "少腹逐瘀湯이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향", 19(2), pp.141~161 (2006)
- "加味紅藤湯 직장내 투여가 子宮內膜症을 유발한 白鼠에 미치는 영향", 19(3), pp.109~120 (2006)
- "加味歸朮破湯이 실험적으로 유발된 흰쥐의 子宮內膜症에 미치는 영향", 19(2), pp.162~185 (2006)
- "丹參이 子宮內膜症 흰쥐에 미치는 영향", 19(3), pp.95~107 (2006)
- "中性瘀血藥鍼이 子宮內膜症 白鼠에 미치는 영향", 9(1), pp.83~94 (2006)
- "八珍湯이 子宮內膜症을 유발한 흰쥐에 미치는 영향", 19(3), pp.83~94 (2006)
- "溫經湯이 자궁내막증 유발 백서에 미치는 영향", 19(2), pp.18~33 (2006)
- "산삼약침이 자궁내막증 유발 흰쥐에 미치는 영향", 23(5), pp.55~67 (2006)
- "보기약류의 면역약리학적 고찰", 9(2), pp.159~171 (2001)
- "黃에 의한 Helper T 세포의 생존 및 활성증가", 15(4), pp.560~565 (2001)
- "수종 한약재가 면역 반응에 미치는 영향", 18(2), pp.43~57 (1997)
- "Endometriotic disease:the role of the peritoneal fluid", 4, pp.741~751 (1998)
- "卵巢囊腫을 韓藥內服 및 약물 保留灌腸法으로 치료한 치험 1례", 13(1), pp.589~596 (2000)
- "속발성월경통을 한약내복 및 한약보류관장법으로 치료한 치험 2례", 12(1), pp.1~10 (1999)
- "만성골반염을 한방 치료한 치험일례 (한약내복약과 보류관장치료 중심으로)", 15(3), pp.181~189 (2002)
- "골반염 치료를 위해 사용된 보류관장요법에 관한 문헌적 고찰 (중국 잡지를 중심으로)", 15(2), pp.91~ (2002)
- "紅藤湯이 LPS 膣內 주입 생쥐에 미치는 抗炎症 효과", 18(1), pp.81~93 (2005)
- "康寧湯의 經口와 直腸投與의 항염증효과 비교연구", 16(3), pp.141~161 (2003)
- "Studies on the surgical induction of endometriosis in the rat", pp.684~694 (1985)
- "임상 부인과 내분비학", pp.445~460 (2001), 서울:고려의학
- "산부인과 질환의 최신지견", pp.32~ (2005), 서울:대신서원
- "The suppression of peritioneal cellular immunity in women with endometriosis could be restored after gonadotropin releasing hormone agonist treatment", 35, pp.510~516 (1996)
- "婦科專病中醫臨床診治", pp.490~532 (2000), 北京:人民衛生出版社
- "今日中醫婦科", pp.104~106 (2000), 北京:人民衛生出版社
- "자궁내막증의 한의학 치료에 관한 연구", 15(2), pp.126~143 (2002)
- "黃帝內經素問", pp.124~286 (1995), 서울:동양의학연구원출판사
- "加味八珍湯이 免疫調節作用에 미치는 영향", 12(2), pp.198~224 (1999)
- "Association of interleukin-6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis", 81(8), pp.764~771 (2002)
- "Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells", 86(12), pp.5765~5773 (2001)
- "Basal and stimulated secretion of cytokines by peritoneal marcrophages in women with endometriosis", 65, pp.925~930 (1996)
- "Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis", 54, pp.82~87 (2002)
- "Role of cytokines in progression of endometriosis", 47, pp.34~39 (1999)
- "Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial", 17, pp.426~431 (2002)
- "Increased monocyte chemotactic protein-1 level and activity in the peripheral blood of women with endoometriosis", 175, pp.1620~1625 (1996)
- "Increase in the production of interleukin-6, interleukin-10, and interleukin-12 by lipopolysaccharide-stimulated peritoneal macrophages from women with endometriosis", 41(1), pp.106~111 (1999)
- "Peritoneal fluid cytokines and the relationship with endometriosis and pain", 11(2), pp.380~386 (1996)
- "Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin -releasing hormone analogue, ultrasound -guided drainage, and intracystic recombinant interleukin-2", 83(4), pp.873~877 (2005)
- "Enhanced interleukin-4 expression in patients with endometriosis", 67(6), pp.1059~1064 (1997)
- "Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis", pp.294~299 (1994)
- "Cytokines in the peritoneal fluid of patients with endometriosis", pp.45~50 (1993)
- "Vascular endotherlial growth factor and interleukin-6 in peritoneal fluid of women with endometriosis", 73, pp.166~170 (2002)
- "Increased level of interleukin-6 and interleukin-10 in the peritoneal fluid of patients with endometriosis", 174, pp.1522~1526 (1996)
- "Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis", 65(6), pp.1125~1129 (1996)
- "Progesterone resistance in endometriosis: link to failure to metabolize estradiol", 248(1-2), pp.94~103 (2006)
- "Mice lacking progesterone receptor exhibit pleiotropic reprductive abnormalities", 9, pp.2266~2278 (1995)
- "Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus", 60, pp.1158~1165 (1999)
- "Mutual and intercompartmental regulation of estrogen receptor expression in the mouse uterus", 59, pp.1143~1152 (1998)
- "세포분자면역학 제5판", pp.243~274 (2005), 서울:도서출판 범문사
- "Altered maturation and function of peritoneal macrophage A new hypothesis of endometriosis", pp.783~789 (1987)
- "임상병리파일", pp.717~729 (2003), 서울:의학문화사
- "이식신 생검에서 비만세포의 임상적 의의", 63(3), pp.201~205 (2002)
- "Regulation of the expression of IL-6 in human monocytes", j immu(l), pp.4339~4345 (1989)
- "Multiple forms of IFN-β IL-6 in serum and body fluids during acute bacterial infection", j immu(l), pp.948~953 (1989)
- "Host defense against infections and inflammations role of the multifunctional IL-6", IFN-β cytokine, 1989, 549~557
- "IL-6 and acute phase plasma proteins in peritoneal fluid of women with endometriosis", Clin Chim Acta
- "蒲公英 추출물이 子宮內膜症 白鼠에 미치는 영향", 19(3), pp.69~82 (2006)
